Log into your Newser account
Joined Newser on:
Find what you're looking for
More about Newser:
Want to contribute?
Suggest a Story
Get our apps:
Install our app:
Stories 1 - 20 |
Jan 6, 2023 2:21 PM CST
FDA Approves Early Treatment Alzheimer's Drug
Drug to be sold as Lequembi has safety concerns, however
- A drug found to slow the progression of Alzheimer's disease received federal approval on Friday for patients dealing with mild impairment. Lecanemab was effective in clinical trials but raised safety concerns, and experts say the benefits are not overwhelming, NBC News reports. Nevertheless, the FDA fast-tracked its approval, not...
Scientists Report Success
on Blood Test for Alzheimer's
Dec 29, 2022 12:39 PM CST
Scientists Report Success on Blood Test for Alzheimer's
Study suggests procedure could eliminate the need for brain imaging or painful spinal taps
- A new blood test has the potential to make it easier, cheaper, and less painful to diagnose Alzheimer's. Researchers writing in the journal
say their test fared well in a study involving 600 patients in picking up a telltale marker of brain neurodegeneration, per a news release . A...
Learns of Health
Nov 21, 2022 10:39 AM CST
Chris Hemsworth Learns of Health Risk While Making Show
Actor has an increased risk for Alzheimer's, he discovers on 'Limitless'
- Chris Hemsworth got an unwanted surprise when participating in the
on Disney+. Blood tests revealed that the then-37-year-old
star has roughly 10 times the average risk of developing Alzheimer's because both his parents have a gene known as APOE4. "It was initially pretty...
Dementia Clues Appear
Almost a Decade
in case you missed it
Oct 16, 2022 4:20 PM CDT
Dementia Clues Appear Almost a Decade Before Diagnosis
Individuals showing signs of cognitive impairment could be key in treatment trials
- Memory loss and cognitive impairment may be detectable up to nine years before an official dementia diagnosis, according to research offering some hope for early intervention. Alzheimer's and dementia are hard to treat, as diagnosis usually comes after symptoms appear, at which point it may be too late to...
After Aduhelm Debacle, New
Alzheimer's Drug Emerges
Sep 28, 2022 7:39 AM CDT
After Aduhelm Debacle, New Alzheimer's Drug Emerges
Biogen, partner Eisai: Clinical trial for lecanemab shows promising 27% slowing of cognitive decline
- Last year, the FDA approved aducanumab , marketed as Aduhelm , a controversial drug made by Biogen and its Japanese partner Eisai to treat Alzheimer's. Things didn't go well, though, with expert opposition to the costly medication and a final death blow to its place in the market after Medicare...
Suggestions of Fraud Rattle
Alzheimer's Research Field
Jul 26, 2022 10:35 AM CDT
Suggestions of Fraud Rattle Alzheimer's Research Field
Investigation casts doubt on fundamental work from 2006
- In the world of Alzheimer's research, it's a bombshell. A new investigation has raised allegations that landmark research conducted in 2006 was fabricated, reports NBC News . The journal
is out with a report that casts serious doubt on the work of Sylvain Lesne of the University of...
Fight Against Aging
Enters a 'Whole New Era'
May 17, 2022 12:09 PM CDT
Fight Against Aging Enters a 'Whole New Era'
Young spinal fluid is seen to improve memory in older mice, per new research
- Researchers are heralding "a whole new era" in the search for Alzheimer's treatments, with a new study suggesting those treatments don't necessarily need to address damage in the brain. Tony Wyss-Coray of Stanford University previously showed infusions of blood from younger animals could reverse the effects of...
'Vicious Cycle' Involves
Mar 17, 2022 12:23 PM CDT
'Vicious Cycle' Involves Napping, Alzheimer's
Study suggests excessive daytime napping is associated with greater risk for the disease among older adults
- Older adults who suddenly find themselves napping longer and more frequently during the day might want to have their brains checked. That's according to researchers at Brigham and Women's Hospital who explored a link between excessive daytime napping and Alzheimer's disease. They analyzed the duration and frequency...
Medicare Makes Big Decision
on New Alzheimer's Drug
Jan 11, 2022 8:10 PM CST
Medicare Makes Big Decision on New Alzheimer's Drug
For now, it will limit Aduhelm coverage to those involved in a clinical trial
- Medicare said Tuesday it will limit coverage of a $28,000-a-year Alzheimer’s drug whose benefits have been widely questioned , a major development in the nation’s tug-of-war over the fair value of new medicines that offer tantalizing possibilities but come with prohibitive prices. The initial determination from the Centers...
Maker Cuts Price
of Alzheimer's Drug
Dec 20, 2021 5:25 PM CST
Maker Cuts Price of Alzheimer's Drug in Half
The medication wasn't catching on at more than $50K per year, Biogen says
- Biogen is slashing the price of its Alzheimer's treatment in half, months after it debuted to widespread criticism over an initial cost that could reach $56,000 annually. The drugmaker said Monday that it will cut the wholesale acquisition cost of the drug by about 50% next month. That...
Death Raises New Concern
Over Alzheimer's Drug
Nov 24, 2021 9:50 AM CST
Death Raises New Concern Over Alzheimer's Drug
Critics say Aduhelm approval was rushed
- Aduhelm, the Alzheimer’s drug approved this summer in a process that led some FDA advisers to quit , is the subject of new controversy. A 75-year-old woman in Canada participating in a clinical trial died in September after going to the hospital for a seizure, the
New York Times
Alzheimer's Vaccine Delivered
via the Nose to Be Tested
Nov 17, 2021 11:50 AM CST
Alzheimer's Vaccine Delivered via the Nose to Be Tested
The vaccine is intended to both prevent Alzheimer's and slow its progress
- Dr. Howard Weiner has spent 20 years on research leading up to this moment: the "landmark first human trial" of an Alzheimer's disease nasal vaccine. Sixteen people ranging in age from 60 to 85 will get two doses over the course of two weeks at the Ann Romney...
Cabbies' 'Remarkable Brains'
Help Alzheimer's Research
Nov 10, 2021 5:05 PM CST
Cabbies' 'Remarkable Brains' Help Alzheimer's Research
London drivers map routes during MRI scans
- The brains of London cabdrivers aren't like other people's. Before they're hired, prospective drivers study the city's streets for years and memorize thousands of routes, the
reports. And it's not just a matter of remembering information long enough to pass the tests; human...
Cops: Wife Duped Husband for
Years, to the Tune of $600K
in case you missed it
Oct 31, 2021 8:45 AM CDT
Cops: Wife Duped Husband for Years, to the Tune of $600K
Donna Marino's spouse didn't have Alzheimer's but she made him think he did to control his money
- For two decades, a Connecticut man says he let his wife handle virtually all of his finances for him, a move he apparently felt even more necessary once he was diagnosed with Alzheimer's. At least, he thought he'd been diagnosed with Alzheimer's. East Haven police say that'...
2 Health Care Systems
Won't Use Aduhelm Yet
Jul 15, 2021 3:35 PM CDT
2 Health Care Systems Won't Use Aduhelm Yet
Cleveland Clinic, Mount Sinai wait for results of investigation into FDA approval process
- Although a new drug for treating Alzheimer's cleared the Food and Drug Administration's approval process, a pair of large health systems say it has not cleared theirs. The Cleveland Clinic and Mount Sinai Health System in New York won't administer Aduhelm to patients until they have more...
of Alzheimer's Drug
to Be Reviewed
Jul 9, 2021 2:50 PM CDT
FDA Approval of Alzheimer's Drug to Be Reviewed
Agency chief fears damage to public confidence in process
- The acting head of the Food and Drug Administration wants the agency's inspector general to conduct an independent review of the agency's approval of a new drug to treat Alzheimer's. The approval process, which one outside adviser had called a "sham" as he resigned, has been...
Jul 8, 2021 6:30 PM CDT
FDA Walks Back Broad Alzheimer's Drug Advice
After criticism, agency says label will limit candidates to those with mild symptoms
- After being widely criticized for approving the use of a new drug to treat all Alzheimer's patients, despite only limited evidence that it works, the Food and Drug Administration has stepped back from that decision. The agency announced its new instructions Thursday that say Aduhelm is intended only for...
Jun 30, 2021 6:35 AM CDT
New Alzheimer's Drug Spurs Big Concerns, an Investigation
2 House committees launch inquiry into approval, cost of Biogen's Aduhelm
- It was supposed to have been a "cause for celebration," but instead, it's become a "catastrophe in the making." That's Axios' recent take on Aduhelm , the costly new Alzheimer's drug that was approved by the Food and Drug Administration despite major reservations from...
Another Company to Ask FDA
to Approve Alzheimer's Drug
Jun 24, 2021 7:10 PM CDT
Another Company to Ask FDA to Approve Alzheimer's Drug
Biogen just won approval for its treatment despite experts' dissent
- Eli Lilly is nearly ready to take another shot at getting approval for a possible Alzheimer's drug. The drugmaker said Thursday that it plans to submit its potential treatment donanemab to the Food and Drug Administration later this year. The announcement comes a few weeks after the FDA approved...
Cost of Alzheimer's Drug Could
Push Medicare to the Brink
Jun 11, 2021 1:00 PM CDT
Cost of Alzheimer's Drug Could Push Medicare to the Brink
Biogen product would nearly double program's medication budget, though it might not work
- The Food and Drug Administration's approval of a new drug to treat Alzheimer's disease could have enormous implications not just for patients, but for Medicare—even pushing the program toward collapse. FDA approval historically has meant Medicare will cover the cost of the medication, but with Biogen's...
Stories 1 - 20 |
Popular on Newser
China Responds to Balloon Hit, but Its Options Are Limited
Missing Missouri Children Found in Florida Supermarket
Hashtag 'Died Suddenly' Is Up 740% in 2 Months
Watch Fighter Jet Take Down China's Balloon
Women Are Suffering Unnecessarily From Menopause
On This Day:
10 Years of Headlines
We see that you're using an ad-blocker.
To read our stories, you'll need to
turn off your ad-blocker.
As an advertising-supported site,
Newser can't exist without ads.
Turn off your ad-blocker
(for Newser only)
One last step.
You have to do this part yourself.
But you're a smartie, and we'll help you out.
1. Click on your ad-blocker icon in your browser.
(It might look like this
2. Every ad-blocker is a bit different, but look for
an option like disable, whitelist, or trust and click it.
Thanks so much.